Loading clinical trials...

Melatonin as Adjuvant Therapy in Breast Cancer Patients | Clinical Trials | Clareo Health

UNKNOWNPhase 2/3NCT01557478

Melatonin as Adjuvant Therapy in Breast Cancer Patients

The study evaluate the effect of melatonin in improving quality of life and reducing post operative pain and chemotherapy-induced toxicity in breast cancer patients. This is a multi-center, randomized...

Lead sponsor: Khon Kaen University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

PhasePHASE2/PHASE3

Enrollment166

Start dateMar 2012

Last updatedJan 8, 2015

Condition

Stage II and III Breast Cancer

Locations shown

Srinagarind Hospital

Khon Kaen, Changwat Khon Kaen

Maharat Nakorn Ratchasima Hospital

Nakorn Ratchasima, Nakorn Ratchasima

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions